Replimune Group, Inc. (REPL) has 20 known insider and institutional holders on record. The largest holder is Omega Fund IV, L.P. with 4,773,542 shares. Other notable holders include Atlas Venture Fund X, L.P. and Coffin Robert.
Over the last 12 months, insiders have made 18 transactions in REPL stock — 5 buys (valued at RSU Award) and 12 sells (valued at $962.48K). Insider selling has exceeded buying during this period.
REPL Insider Ownership
Top Holder
Omega Fund IV, L.P.
4,773,542 shares
Buys (12 mo)
5
$0.00 value
Sells (12 mo)
12
$962.48K value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Omega Fund Iv, L.p. |
10 Percent Owner |
4,773,542 |
2021-11-23 |
|
| 2 |
Atlas Venture Fund X, L.p. |
10 Percent Owner |
2,486,296 |
2020-09-17 |
|
| 3 |
Coffin Robert |
Director |
1,821,872 |
2024-05-20 |
|
| 4 |
Astley-sparke Philip |
Director |
1,380,071 |
2026-02-20 |
|
| 5 |
Atlas Venture Opportunity Fund I, L.p. |
Officer |
1,100,000 |
2019-11-20 |
|
| 6 |
Love Colin |
Chief Operating Officer |
777,345 |
2024-05-20 |
|
| 7 |
Patel Sushil |
Chief Executive Officer |
533,576 |
2025-12-19 |
|
| 8 |
Xynos Konstantinos |
Chief Medical Officer |
199,685 |
2025-12-19 |
|
| 9 |
Hill Emily Luisa |
Chief Financial Officer |
194,368 |
2025-12-19 |
|
| 10 |
Sarchi Christopher |
Chief Commercial Officer |
151,588 |
2026-04-06 |
|
| 11 |
Lewis Tanya |
Chief Dev. Op. Officer |
135,293 |
2023-06-15 |
|
| 12 |
Franchi Jean M. |
Chief Financial Officer |
128,748 |
2023-05-18 |
|
| 13 |
Esposito Pamela |
Chief Business Officer |
86,333 |
2023-09-13 |
|
| 14 |
Schwendenman Andrew |
Chief Accounting Officer |
78,284 |
2025-12-19 |
|
| 15 |
Gorgol Stephen A |
Chief Accounting Officer |
66,050 |
2020-04-02 |
|
| 16 |
Baker Bros. Advisors Lp |
10 Percent Owner |
64,000 |
2025-03-07 |
|
| 17 |
Kaufman Howard |
Chief Medical Officer |
58,067 |
2019-12-19 |
|
| 18 |
Slattery Joseph P |
Director |
32,000 |
2025-04-03 |
|
| 19 |
Peeples-dyer Veleka |
Director |
32,000 |
2025-04-03 |
|
| 20 |
Oliger Christy J. |
Director |
32,000 |
2025-04-03 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-04-02 |
Sarchi Christopher |
Chief Commercial Officer |
Informative Sell |
6,500 |
$8.01 |
$52.07K |
| 2026-02-18 |
Astley-sparke Philip |
Director |
Gift (Given) |
25,000 |
- |
- |
| 2025-12-19 |
Sarchi Christopher |
Chief Commercial Officer |
RSU Award |
35,000 |
- |
- |
| 2025-12-19 |
Schwendenman Andrew |
Chief Accounting Officer |
RSU Award |
10,000 |
- |
- |
| 2025-12-19 |
Xynos Konstantinos |
Chief Medical Officer |
RSU Award |
60,000 |
- |
- |
| 2025-12-19 |
Patel Sushil |
Chief Executive Officer |
RSU Award |
200,000 |
- |
- |
| 2025-12-19 |
Hill Emily Luisa |
Chief Financial Officer |
RSU Award |
60,000 |
- |
- |
| 2025-12-09 |
Dhingra Kapil |
Director |
Informative Sell |
3,169 |
$10.40 |
$32.96K |
| 2025-12-02 |
Patel Sushil |
Chief Executive Officer |
Informative Sell |
10,000 |
$11.13 |
$111.3K |
| 2025-11-17 |
Sarchi Christopher |
Chief Commercial Officer |
Informative Sell |
5,208 |
$9.10 |
$47.39K |
| 2025-11-17 |
Xynos Konstantinos |
Chief Medical Officer |
Informative Sell |
7,248 |
$9.10 |
$65.96K |
| 2025-08-15 |
Hill Emily Luisa |
Chief Financial Officer |
Informative Sell |
9,154 |
$5.37 |
$49.16K |
| 2025-05-20 |
Sarchi Christopher |
Chief Commercial Officer |
Informative Sell |
3,749 |
$8.05 |
$30.18K |
| 2025-05-20 |
Schwendenman Andrew |
Chief Accounting Officer |
Informative Sell |
3,287 |
$8.05 |
$26.46K |
| 2025-05-20 |
Xynos Konstantinos |
Chief Medical Officer |
Informative Sell |
7,952 |
$8.06 |
$64.09K |
| 2025-05-20 |
Patel Sushil |
Chief Executive Officer |
Informative Sell |
25,105 |
$8.06 |
$202.35K |
| 2025-05-20 |
Hill Emily Luisa |
Chief Financial Officer |
Informative Sell |
2,535 |
$8.05 |
$20.41K |
| 2025-05-20 |
Astley-sparke Philip |
Director |
Informative Sell |
32,279 |
$8.06 |
$260.17K |
